It investigated the contribution of gene polymorphism to the development of type 2 amiodarone-induced thyrotoxicosis and showed that the risk of AIT2 is 3.18 times higher in the G/T of the DUOX2 gene carriers. The gene discussed is DUOX2; the disease is thyrotoxicosis.